CIOCC HM Sanchinarro
CIOCC HM Sanchinarro
Madrid, Spain1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Less Frequent IV Dosing & Tumor Microenvironment (TME) Study of Nemvaleukin Alfa (ALKS 4230) Monotherapy and in Combination With Pembrolizumab (ARTISTRY-3) | neoplasm | Active, not recruiting | Phase 1 / Phase 2 | 2024-06-07 | NCT04592653 |